Skip to main content
Log in

β-Galactosidase-deficient human fibroblasts: uptake and processing of the exogenous precursor enzyme expressed by stable transformant COS cells

  • Original Investigations
  • Published:
Human Genetics Aims and scope Submit manuscript

Summary

COS-1 cells were transfected by electroporation with a cDNA for human acid β-galactosidase cloned in our laboratory and stable transformants expressing the enzyme activity were selected. The precursor form of the enzyme was secreted in large quantities into the culture medium. The fibroblasts from patients with GM1-gangliosidosis or Morquio B disease showed a remarkable increase of enzyme activity, up to the normal level, after culture in this medium for 2 days; the amount of uptake was essentially the same as that for the precursor form in human fibroblasts. After endocytosis, the precursor molecules were processed normally to the mature form and remained as stable as those produced by human fibroblasts. On the other hand, cells from galactosialidosis patients did not show any increase of enzyme activity in a similar experiment. It was concluded that the transformants are useful as the source of precursor proteins for the study of intracellular turnover of enzyme molecules in mutant cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the prinicple of protein-dye binding. Anal Biochem 72:248–254

    Article  CAS  PubMed  Google Scholar 

  • Creek KE, Sly WS (1984) The role of the phosphomannosyl receptor in the transport of acid hydrolases to lysosomes. In: Dingle JT, Dean RT, Sly WS (eds) Lysosomes in biology and pathology, vol 7. Elsevier, Amsterdam, pp 63–82

    Google Scholar 

  • D'Azzo A, Hoogeveen A, Reuser AJJ, Robinson D, Galjaard H (1982) Molecular defect in combined β-galactosidase and neuraminidase deficiency in man. Proc Natl Acad Sci USA 79:4335–4339

    Google Scholar 

  • Diggelen OP van, Schram AW, Sinnott ML, Smith PJ, Robinson D, Galjaard H (1981) Turnover of β-galactosidase in fibroblasts from patients with genetically different types of β-galactosidase deficiency. Biochem J 200:143–151

    Google Scholar 

  • Galjart NJ, Gillemans N, Harris A, Horst GTJ van der, Verheijen FW, Galjaard H, D'Azzo A (1988) Expression of cDNA encoding the human “protective protein” associated with lysosomal β-galactosidase and neuraminidase: homology to yeast proteases. Cell 54:755–764

    Google Scholar 

  • Harlander SK (1981) Transfection of Streptococcus lactis by electroporation. In: Ferretti JJ, Curtiss R (eds) Streptococcus genetics. American Society for Microbiology. Washington, DC, pp 229–233

    Google Scholar 

  • Hasilik A, Neufeld EF (1980) Biosynthesis of lysosomal enzymes in fibroblasts. J Biol Chem 255:4937–4945

    Google Scholar 

  • Hoogeveen AT, Verheijen FW, Galjaard H (1983) The relation between human lysosomal β-galactosidase and its protective protein. J Biol Chem 258:12143–12146

    Google Scholar 

  • Hoogeveen AT, Graham-Kawashima H, D'Azzo A, Galjaard H (1984) Processing human β-galactosidase in GM1-gangliosidosis and Morquio B disease. J Biol Chem 259:1974–1977

    Google Scholar 

  • Hoogeveen AT, Reuser AJJ, Kroos M, Galjaard H (1986) GM1Gangliosidosis: defective recognition site on β-galactosidase precursor. J Biol Chem 261:5702–5704

    Google Scholar 

  • Horst GTJ van der, Kleijer WJ, Hoogeveen AT, Huijman JGM, Blom W, Diggelen OP van (1983) Morquio B syndrome: a primary defect in β-galactosidase. Am J Med Genet 16:261–275

    Google Scholar 

  • Jalanko A, Kallio A, Ruohonen-Lehto M, Soderlund H, Ulmanen I (1988) An EBV-based mammalian cell expression vector for efficient expression of cloned coding sequences. Biochim Biophys Acta 949:206–212

    Google Scholar 

  • Ko Y, Suzuki Y (1985) Experimental studies on enzyme replacement therapy of genetic β-galactosidase deficiency. II. Studies on β-galactosidase human tissues. Nippon Shonika Gakkai Zasshi 89:553–559

    Google Scholar 

  • Kornfeld S (1986) Trafficking of lysosomal enzymes in normal and disease states. J Clin Invest 77:1–6

    Google Scholar 

  • Morreau H, Galjart NJ, Gillemans N, Willemsen R, Horst GTJ van der, D'Azzo A (1989) Alternative splicing of β-galactosidase mRNA generates the classic lysosomal enzyme and a β-galactosidase-related protein. J Biol Chem 264:20655–20663

    Google Scholar 

  • Motegi Y, Fujinaga T, Tamura H, Kuroume T, Omura K, Nanba E, Suzuki Y (1987) Severe infantile galactosialidosis: a case report. Nippon Shonika Gakkai Zasshi 91:1459–1464

    Google Scholar 

  • Nanba E, Tsuji A, Omura K, Suzuki Y (1987) Galactosialidosis: direct evidence that a 46-kilodalton protein restores deficient enzyme activities in fibroblasts. Biochem Biophys Res Commun 144:138–142

    Google Scholar 

  • Nanba E, Tsuji A, Omura K, Suzuki Y (1988a) GM1-gangliosidosis: abnormalities in biosynthesis and early processing of β-galactosidase in fibroblasts. Biochem Biophys Res Commun 152:794–800

    Google Scholar 

  • Nanba E, Tsuji A, Omura K, Suzuki Y (1988b) Galactosialidosis: molecular heterogeneity in biosynthesis and processing of protective protein for β-galactosidase. Hum Genet 88:329–332

    Google Scholar 

  • Nolan CM, Sly WS (1989) I-cell disease and pseudo-Hurler polydystrophy: disorder of lysosomal enzyme phosphorylation and localization. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th edn. McGrawHill, New York, pp 1589–1601

    Google Scholar 

  • O'Brien JS (1989) β-Galactosidase deficiency (GM1-gangliosidosis, galactosialidosis, and Morquio syndrome type B); ganglioside sialidase deficiency (mucolipidosis IV). In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th edn. McGraw-Hill, New York, pp1797–1806

    Google Scholar 

  • Okada S, O'Brien JS (1968) Generalized gangliosidosis: β-galactosidase deficiency. Science 160:1002–1004

    Google Scholar 

  • Oshima A, Kyle JW, Miller RD, Hoffmann JW, Powell PP, Grubb JH, Sly WS, Tropak KS, Guise KS, Gravel RA (1987) Cloning, sequencing, and expression of cDNA for human β-glucuronidase. Proc Natl Acad Sci USA 84:685–689

    Google Scholar 

  • Oshima A, Tsuji A, Nagao Y, Sakuraba H, Suzuki Y (1988) Cloning, sequencing, and expression of cDNA for human β-galactosidase. Biochem Biophys Res Commun 157:238–244

    Google Scholar 

  • Proia RL, D'Azzo A, Neufeld EF (1984) Association of α and β-subunits during the biosynthesis of β-hexosaminidase in cultured human fibroblasts. J Biol Chem 259:3350–3354

    Google Scholar 

  • Sakuraba H, Aoyagi T, Suzuki Y (1982) Galactosialidosis (β-galactosidase-neuraminidase deficiency): a possible role of serinethiol proteases in the degradation of β-galactosidase molecules. Clin Chim Acta 125:275–282

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oshima, A., Itoh, K., Nagao, Y. et al. β-Galactosidase-deficient human fibroblasts: uptake and processing of the exogenous precursor enzyme expressed by stable transformant COS cells. Hum Genet 85, 505–508 (1990). https://doi.org/10.1007/BF00194225

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00194225

Keywords

Navigation